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Summary : Humoral and lymphocyte responses to Mycobacterium tuberculosis culture
filtrate antigens were studied in active pulmonary tuberculosis (ATB) cases (n = 62),
inactive (cured/quiescent) tuberculosis (ITB) patients (n = 62) and healthy control
subjects (n = 60).
Active tuberculosis patients showed very high antibody titre to M. tuberculosis culture
filtrate antigens as compared to ITB and control subjects. M. tuberculosis antigens from
17 to 80 kDa were recognised by the plasma of all ATB and ITB patients as well as
control subjects. However, the 38, 32-34, 30-31 and 27 kDa antigens were recognised
more by the ATB patients as compared to the control subjects while the 64/66 kDa
antigen was mostly recognised by the cured patients. Increased lymphocyte responses
were seen with increasing concentrations of M. tuberculosis culture filtrate antigens and
mitogens such as Phytohaemagglutinin (PHA) and Concanavalin-A (Con-A) in ATB and
ITB patients as well as healthy control subjects. However, a low or suppressed
lymphocyte response to PHA, Con-A and M. tuberculosis culture filtrate antigens was
seen in ATB patients compared to ITB patients and control subjects.
The study suggests that during the active stage of the disease, the humoral immune
response is augmented but the antigen and mitogen induced lymphocyte response (an in
vitro correlate of CMI response) is suppressed. This further suggests that the humoral
immune response regulates the CMI response during the active stage of the disease;
when the disease is cured, the antibody response declines and the lymphocyte response
to antigens and mitogens increases to the same level as found in controls. This suggests
that normal immune status gets restored in cured patients.
Key words : Antibody response; Antigen recognition; Lymphocyte response;
M. tuberculosis antigens; Mitogens; Pulmonary tuberculosis.
INTRODUCTION rapidly within the granuloma, releasing large
quantities of glycolipid and polysaccharide
Tuberculosis is a chronic infectious disease antigens into the draining lymphnodes, lead-
regulated almost entirely by the cell-mediated ing to a predominantly humoral immune re-
immune response (CMI) of the host against M. sponse2. On the other hand, viable mycobac-
tuberculosis. When bacillary antigens are tria release small quantities of glycoprotein an-
present at low levels, the CMI response causes tigens which induce a delayed type hypersen-
macrophages to accumulate, become activated sitivity (DTH) and cell-mediated immunity re-
and then destroy the bacilli. However, when sponse3. As more and more tubercle bacilli are
bacillary antigens are present at high levels, killed by the immune host, considerable quan-
the CMI response causes necrosis of tissues1. tities of glycolipid and polysaccharide anti-
The immune response against M. tuberculosis gens are released from the cell-wall of M. tu-
involves both macrophages and lymphocytes. berculosis. These antigens are responsible for
Dead organisms are broken down relatively increasing humoral response (IgM, IgG, IgA)
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which usually peaks after the T-cell mediated
immune response has declined4.
A number of studies have been carried out
to understand the immune response against
M. tuberculosis during the active stage of the
disease5-12. However, no attempt appears to
have been made to understand the immune
status (cell-mediated and humoral immunity)
of patients after successful treatment (cured
patients). The present study was aimed at the
humoral immunity and lymphocyte response
to M. tuberculosis culture filtrate antigens in ac-
tive (ATB) as well as cured (ITB) patients and
healthy control subjects. Moreover, lym-
phocyte response to mitogens such as Phyto-
haemagglutinin (PHA) and Concanavalin-A
(Con-A) was also studied.
MATERIAL AND METHODS
Study subjects
Active tuberculosis (ATB) patients
Patients attending the Tuberculosis Re-
search Centre (TRC), Chennai, with respirato-
ry symptoms and radiographic abnormalities
suggestive of pulmonary tuberculosis were
studied. These patients had sputum positive
for M. tuberculosis by smear and culture. Blood
specimens were taken from them before the
start of chemotherapy. Among the 62 ATB pa-
tients studied, there were 55 males (mean age
± S.E. = 38 ± 1.6) and 7 females (mean age ±
S.E. = 29 ± 3.1).
Inactive (Cured) tuberculosis (ITB) patients
These patients had received short course
anti-tuberculosis chemotherapy at TRC for 6-8
months’ duration 10-15 years back. At the time
of blood specimen collection, all these cured
patients were rechecked to be quiescent. Of
the 62 such patients studied, 44 were males
and 18 were females. Mean age with SE was 42
± 1.6 for males and 35 ± 1.9 for females.
Control subjects
Healthy spouses and other family contacts
(n= 21) of cured tuberculosis patients and
clinicians, social workers, health visitors,
laboratory volunteers and other staff (n = 39)
working at TRC for more than 3 years were
studied. Of the 60 control subjects, 25 were
males and 35 were females. Mean age with SE
was 38 ± 1.7 for males and 37 ± 1.4 for females.
The patients and their spouses were not
consanguineous to each other, nor were the
control subjects related to any of the patients.
But, all belonged to the same ethnic origin and
were living in and around Chennai.
Peripheral blood
Peripheral blood mononuclear cells (PBMC)
were separated out from heparinised (20
units/ml) blood specimens using Ficoll-
hypaque density gradient centrifugation13.
Plasma was used for the estimation of IgG
antibody titre and antigen recognition pattern
against M. tuberculosis culture filtrate antigens.
PBMC were used for studying lymphocyte
response to M. tuberculosis antigens and
mitogens.
M. tuberculosis culture filtrate (Antigen)
M. tuberculosis culture filtrate antigen was
prepared as described earlier14. Briefly, H37Rv
strain was grown for 6 weeks (late logarithmic
phase) as a surface pellicle on Sauton’s
medium at 37°C. The culture was centrifuged
and the supernatant fluid was filtered. The
culture filtrate proteins were precipitated with
80% ammonium sulphate and dialysed against
PBS (pH 7.4). The dialysed protein was
lyophilised and resuspended in minimal
volume of sterile PBS Its protein concen-
tration was estimated and it was stored at -
20°C until required. The antigen concen-
trations used for eliciting lymphocyte response
were 0.1, 1.0 and 10.0 µg/ml of culture.
Mitogens
The mitogens Phytohaemagglutinin (PHA)
(Wellcome Diagnostics, Dartford, U.K) and
Concanavalin-A (Con-A) (Sigma Chemicals
Co., St. Louis, U.S.A.) were used at 0.1, 1.0 and
10.0 µg/ml concentrations.
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Enzyme linked immunosorbent assay (ELISA)
The IgG antibody titre against M. tuberculo-
sis culture filtrate antigens was measured by
ELISA as described earlier14. Antigen coated
(5 µg/ml) ELISA plates (polyvinyl chloride)
(Costar, Cambridge, Ma. USA) were incubated
with serially diluted plasma specimens (from
1 : 5 to 1 : 20480) at 37°C. Rabbit anti-human
IgG peroxidase conjugate (Bangalore Genet
Pvt. Ltd., Bangalore) was used as the second
antibody (1 : 1000) and incubated. Colour was
developed using orthophenylenediamine
(OPD 0.5 mg/ml) and 0.1% hydrogen perox-
ide as substrate. The optical density (OD) was
measured at 490 nm in an ELISA reader (Titer-
tek multiscan plus. MKII, Flow Laboratories
International, Lugano, Switzerland). Twice the
mean OD value of the blank was used as the
cut-off point. Plasma specimens showing OD
values above the cut-off point were taken as
positive and the corresponding titre values
were recorded.
Immunoblotting
Culture filtered antigen (50 µg/cm of gel)
was loaded onto a 12.5% sodium dodecyl
sulphate polyacrylamide slab gel
electrophoresis (Protean Bio-Rad Laboratories.
California, USA) using a discontinuous tris-
buffered system as described elsewhere15. A
molecular weight marker was run along with
the antigen and stained with 0.5%. Coomasie
 brilliant blue (R250 - Bio-Rad Laboratories,
California, USA). After electrophoresis,
proteins were transferred electrophoretically
to nitrocellulose paper (NCP) (Advanced
Microdevices Pvt. Ltd., Ambala. India) by the
method of Towbin et al., 16 in a Blot Apparatus
(Transblot Apparatus. Bio-Rad Laboratories,
California, USA) for 1 hr at 65 mA constant
current. The NCP strips were treated with the
plasma specimens of patients (1 : 50 dilution)
and rabbit anti-human IgG peroxidase
conjugate as second antibody (1 : 1000
dilution), with hydrogen peroxide as substrate
and colour was developed using 0.04%
diaminobenzidine (Bio-Rad Laboratories,
California, USA) in PBS as the chromogenic
substance. One strip was included as positive
control (hyper immune rabbit serum against
M. tuberculosis H37Rv strain) in each set of
experiments using anti-rabbit IgG peroxidase
as second anti-body (1 : 5000).
Lymphocyte transformation test
The lymphocyte response of ATB, ITB and-
control subjects to M. tuberculosis culture
filtrate antigen was studied, as described
earlier14. Briefly, 0.1 x l06 of PBMC in 200 µl
was cultured with various concentrations (0.1,
1.0 and 10.0 µg/ml) of M. tuberculosis culture
filtrate antigens, 10% autologous plasma for
controls and ITB patients and serum for ATB
patients. Autologous serum was used instead
of plasma to avoid clotting. PBMC cells were
cultured for 6 days in a 96, well ‘U’ bottom
tissue culture plate (Coaster, Cambridge. Ma,
USA), at 37°C and 5% carbon-dioxide in a CO,
incubator (Flow Laboratories Ltd.,
Rickmansworth, Hertz, UK). Tritiated
thymidine (3H) (BARC, Trombay, Mumbai)
was added to each well (1 µCl/well) 16 hrs
before termination. The cells were harvested
and the lymphocyte response to M. tuberculosis
antigen was measured by tritium labelled
thymidine uptake by the cells in a scintillation
system using Beta counter (LKB, USA) and
expressed as counts per minute (cpm). The
mean cpm value of the triplicateculture was
calculated and the stimulation index (SI) was
derived using the formula :
Mean cpm of antigen stimulated
cell cultures
SI =
Mean cpm of cell cultures
without antigen
Statistical Analysis
The results of antibody titres and lym-
phocyte responses are expressed as arithmetic
mean ± S.E. Student’s ‘t’ test was used to as-
sess the significance of the difference between
means. Proportionality test was used for im-
munoblot analysis to asses the significance.
RESULTS
The IgG antibody titre against M.
tuberculosis H37Rv culture filtrate antigens was
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Fig. 1. Antibody titre to M. tuberculosis culture
filtrate antigen in ATB, ITB patients and
control subjects. Results are expressed as
arithmetic mean ± S.E. The number of
subjects studied was : Controls : n = 60;
A T B  :  n = 6 2 ;  I T B  :  n = 6 2   
Controls Vs ATB P < 0.01;
Controls Vs ITB P < 0.01;
ATB Vs ITB P < 0.01
higher in ATB patients as compared to ITB
patients and controls (Figure 1). Further, the
antibody titre of ITB patients was higher
compared to that of control subjects. The
differences in the antibody titres were quite
significant between the different groups
studied (Controls Vs ATB - P < 0.01 : Controls
Vs ITB - P < 0.01; ATB Vs ITB - P < 0.01).
Most of the M. tuberculosis culture filtered
antigens, from 17 kDa to 80 kDa were
recognised by the IgG antibodies present in
the plasma of active and inactive TB patients.
More inactive tuberculosis patients recognised
64/66 kDa antigen compared to the active TB
patients (P < 0.01) and control subjects (P <
0.01). Both active and in active TB patients
recognised 38 kDa antigens significantly more
often compared to control subjects (ATB Vs
Controls, P < 0.05 : ATB Vs ITB P < 0.05).
Further, 30/31 and 32/34 kDa antigens were
also recognised more often by ATB and ITB
M. tuberculosis H37Rv CULTURE FILTRATE ANTIGENS (Mol. wt. in KDa)
Fig. 2. M. tuberculosis culture filtrate antigen recognition pattern by the plasma of ATB and ITB patients
and control subjects Percentage of subjects recognising the various antigens of M. tuberculosis
culture filtrate is represented. The number of subjects studied in each group was : Controls : n = 60;
ATB : n=62; ITB : n=62.
(i) Significant recognition of 52/54 kDa, 38 kDa, 27 kDa and 17 kDa antigens was seen:
Controls Vs ATB - P < 0.05; ITB Vs ATB-P < 0.05
(ii) Significant recognition of 64/66 kDa antigen was seen : Controls Vs ITB-P < 0.01; ATB Vs ITB-P <
0.01
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patients compared with controls; 27 kDa
antigen was recognised more often by active
TB patients compared to ITB patients (P c
0.05) and control subjects (P < 0.05). The
recognition of antigens 52-54 kDa, 38 kDa, 27
kDa and 17 kDa was significantly higher in
ATB patients compared with ITB and control,
subjects (Figure. 2).
An increased lymphocyte response with in-
creasing concentrations (0.1 µg, 1.0 µg, and
10.0 µg) of M. tuberculosis culture filtrate anti-
gen was seen in ATB, ITB patients and control
subjects (Table). The lymphoproliferative re-
sponses of ITB patients to antigenic stimula-
tion was significantly higher than controls and
ATB patients at all the three (0.1 µg/ml, 1.0
µg/ml and 10.0 µg/ml) concentrations studied
(Control Vs ATB-P < 0.01; Control Vs ITB-P <
0.01; ATB Vs ITB-P < 0.01).
µg/ml concentrations (P < 0.01). There was
not much difference at the higher concen-
tration (10.0 µg/ml). Moreover, significantly
higher lymphocyte response to PHA was seen
in the ITB patients compared with ATB
patients irrespective of the concentrations of
PHA studied. Not much difference was seen
among controls and patients at lower concen-
tration (0.1 µg/ml) of Con-A but values were
significantly higher in controls compared with
ATB patients at higher concentrations (1.0 µg/
ml and 10.0 µg P < 0.01). Further, ITB patients
showed a significantly increased response to
Con-A at 1.0 µg and 10.0 µg (P < 0.01)
compared with ATB patients. The responses of
ITB patients to Con-A concentration were
similar to that of controls (Table).
The mean stimulation indices for PHA were
significantly higher in controls compared with
ATB patients at 0.1 µg/ml (P < 0.01) and 1.0
A decreased lymphocyte response to M.
tuberculosis antigens and mitogens was seen in
all the concentrations studied in ATB patients
compared to control subjects and ITB patients.
However, Con-A at 0.1 µg concentration did
Table Lymphocyte response of healthy control subjects and pulmonary tuberculosis (ATB and ITB)















Mean Stimulation Index ± SE
Control ATB ITB
3.2 ± 0.4 1.4 ± 0.1 8.3 ± 1.7
5.9 ± 0.8 2.5 ± 0.4 17.3 ± 2.7
11.5 ± 1.6 4.5 ± 0.9 31.7 ± 4.9
(n = 58) (n = 50) (n = 44)
10.8 ± 2.4 6.4 ± 2.7 13.2 ± 3.5
82.1 ± 9.5 34.4 ± 7.4 98.8 ± 13.1
82.6 ± 9.4 61.6 ± 11.7 79.8 ± 12.1
(n = 49) (n = 21) (n = 42)
3.4 ± 0.8 3.7 ± 2.4 3.1 ± 0.4
19.6 ± 3.8 5.0 ± 1.1 24.9 ± 5.0
56.7 ± 6.6 21.1 ± 3.0 67.9 ± 9.4
(n = 52) (n = 27) (n = 44)
1. Numbers in parentheses represent actual number of subjects studied.
2. MTb antigen (i) Control Vs ATB : P < 0.01; (10 µg/ml)
(ii) Control Vs ITB : P < 0.01
(iii) ATB Vs ITB : P < 0.01
(P values are significant at 0.1 and 1.0 µg/ml. (P values not given)
3. PHA (i) Controls Vs ATB : P < 0.01 (1 µg/ml)
(ii) ATB Vs ITB P < 0.01 (10 µg/ml)
4. Con-A (i) Controls Vs ATB : P < 0.01 (1 µg and 10 µg/ml)
(ii) ATB Vs ITB : P < 0.01 (1 µg and 10 µg/ml)
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not show any suppression. This decreased
response was significant (P < 0.01) at 1.0 µg
and 10.0 µg concentrations of either the
antigen or the mitogens studied (Table).
DISCUSSION
In the present study, high antibody (IgG
antibody) title to M. tuberculosis culture filtrate
antigens was seen in ATB patients compared
to control subjects and the cured (ITB)
patients. Earlier studies had shown similar
results8,17. This may be due to heavy bacillary
(antigenic) load triggering high B cell
response. It is well established that high
antibody titre is elicited only during the
secondary immune response as IgG
antibodies. The antibody titre in the cured
(ITB) patients was also significantly higher
compared with control subjects, which shows
persistence of high IgG antibody level even in
the cured.
The antigen recognition pattern by these
antibodies revealed that both patients and
control subjects recognised the antigens, from
17 kDa to 80 kDa, as found in other studies
alsol8,19. This suggests that most of the culture
filtrate antigens are immunogenic.
Antibodies to 64-66 kDa antigens were seen
in control subjects as well as patients.
However, a larger proportion of ITB patients
recognised this antigen compared with control
subjects and ATB patients. Emmrich et al.5
have demonstrated that epitopes of 65 kDa
antigen are shared by bacteria such as E. coli
and atypical mycobacteria. Thus, the 65 kDa
antigen elicits a strong B cell response
inducing antibodies controls in as well as in
ATB and ITB patient groups.
The 38 kDa antigen is strongly recognised
by active and inactive tuberculosis patients
compared with the control subjects. Most
smear positive pulmonary tuberculosis
patients had a high antibody titre but
recognition of 38 kDa antigen by inactive
tuberculosis patients suggests that antibody
levels are maintained for a long time. This
suggests that the 38 kDa fraction of M.
tuberculosis is a strong immunogen capable of
evoking a strong B cell memory response.
Recognition of 32 - 34 and 30 - 31 kDa
antigen fractions was found to be only slightly
increased in patients compared with control
subjects, unlike the 38 kDa antigen, and fewer
treated patients recognised this antigen.
Humoral immune response to antigen 85A
and 85B (30 and 31 kDa) has been found to be
much higher in active-tuberculosis patients
compared with the controls20 but not so in
treated patients as in patients undergoing
treatment21.
We found in this study that 27 kDa fraction
in M. tuberculosis culture filtrate antigen was
recognised by active tuberculosis patients but
not by control subjects. However, a small
percentage of ITB patients also recognised this
antigen. Since reports on the nature and
immunogenecity of this antigen are scanty,
more investigations are needed, as it may help
in differentiating ATB patients from healthy
subjects (immunodiagnosis).
Immunity in tuberculosis being a purely
cell-mediated defence7, lymphoproliferative
response or mitogen stimulation have been
widely used as in vitro correlates of cell-
mediated immunity”. In the present study,
patients with active tuberculosis showed a low
lymphocyte response to M. tuberculosis culture
filtrate antigens and mitogens (PHA and Con-
A) compared with control subjects and treated
tuberculosis patients. A low T-cell responsive-
ness was observed in ATB patients even in
respect of mitogen stimulation (Concanavalin-
A). Low T lymphocyte reactivity is well docu-
mented in tuberculosis11. The low responsive-
ness may be attributed to the suppressive
factors secreted by monocytes and
lymphocyte6. Another possibility may be a
shift from Thl (responsible for cell-mediated
immunity) to Th2 (responsible for humoral
immunity) type of cytokine response9,12,23.
Further, preferential sequestration of antigen
specific T cells into the infected areas24 leads to
their absence in peripheral blood. Such
compartmentalisation has been described in
patients with severe pulmonary and or miliary
tuberculosis. Cured patients showed a higher
response to M. tuberculosis culture filtrate
antigens compared with control subjects, may
be due to the presence of sensitised T-cell to
M. tuberculosis antigens suggesting a long-
lived memory T-cell response in these patients
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and supporting the thesis that these antigens
have the potential to evoke strong immuno-
logical memory,
The present study suggests that active
tuberculosis patients elicit a very high
antibody titre but a significantly low
proliferative response to M. tuberculosis
secreted antigens. The picture gets reversed
after successful anti-tuberculosis treatment
producing a better immune status in cured
patients.
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